VA tests new combo therapy to help veterans beat addiction

NCT ID NCT05054738

Ongoing Disease control Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 22, 2026 · Updated 4 times

Summary

This study looks at whether adding a six-session group recovery program and a 90-day home telehealth program can help veterans with substance use disorders drink less and use fewer drugs. About 195 veterans from a VA psychiatric unit will be randomly assigned to one of three groups: the combined program, the telehealth program alone, or usual care. Researchers will track alcohol and drug use, treatment attendance, and community activities for three months after discharge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Combined Recovery Program (behavioral therapy) and Stable & Able home telehealth program
What this could lead to: If successful, this could offer a practical, scalable way to help veterans reduce substance use and stay sober after leaving the hospital.
What could go wrong: This is a relatively small, early-stage study (195 participants) comparing two behavioral programs to usual care. Results may not apply to all veterans, and the benefits may be modest or short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOLISM DUAL DIAGNOSIS SUBSTANCE-RELATED DISORDERS

Contacts and locations

Locations

Ralph H. Johnson VA Medical Center, Charleston, SC

Charleston, South Carolina, 29401-5703, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.